市場調査レポート

商品コード

1707981

アプタマー市場規模、シェア、成長分析、タイプ別、用途別、技術別、エンドユーザー別、地域別 - 産業予測、2025-2032年

Aptamers Market Size, Share, and Growth Analysis, By Type (DNA Aptamers, RNA Aptamers), By Application (Diagnostics, Therapeutics), By Technology, By End-User, By Region - Industry Forecast 2025-2032

出版日: 2025年04月08日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 786,149円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 919,646円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,053,143円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.33円

全表示
概要
目次

概要

サンプル依頼リストに入れる

アプタマーの市場規模は2023年に29億1,000万米ドルとなり、予測期間（2025-2032年）のCAGRは24.6%で、2024年の36億3,000万米ドルから2032年には210億6,000万米ドルに成長する見通しです。

アプタマーの世界市場は、慢性疾患の有病率の上昇と標的治療薬の採用増加により、大きな成長が見込まれています。革新的な診断技術への投資の高まりに支えられた早期診断ソリューションへの需要は、この市場をさらに前進させると思われます。さらに、試験管内選択法（SELEX）技術の進歩はアプタマー開発の機会を高めると予想されます。医学研究開発の急増は、遺伝子治療への関心の高まりとアプタマーの利点に対する意識の高まりと相まって、市場を力強い拡大へと位置づけています。しかし、半減期の短さ、代替品の入手可能性、限定的な受容性、厳しい規制の枠組みといった課題が成長の妨げになる可能性があります。特に、米国やカナダのような新興国開拓地域は、アプタマー・プロバイダーにとって有望な市場として浮上しています。

市場概要
診断
- バイオマーカー検出
- 病原体検出
- 造影剤
- コンパニオン診断
治療薬
- 腫瘍学
- 心血管疾患
- 感染症
- 眼科
- 炎症性疾患および自己免疫疾患
研究開発
- 分子プローブ
- ターゲット検証
- タンパク質相互作用研究
バイオセンサー
- 環境モニタリング
- 食品安全
- バイオ防衛アプリケーション
ドラッグデリバリーシステム
- ターゲット配信
- 制御放出製剤

アプタマー市場規模：技術別

市場概要
セレックス
- 従来のSELEX
- 細胞SELEX
- キャピラリー電気泳動法SELEX
- マイクロ流体SELEX
- ハイスループットSELEX
SELEX後の最適化技術
- 化学修飾
- トランケーション
- 二量体化
- ポリエチレングリコール化

アプタマー市場規模：エンドユーザー別

市場概要
製薬・バイオテクノロジー企業
学術調査機関
臨床検査室
契約調査機関（CRO）
診断検査室

アプタマー市場規模

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024年）

主要企業プロファイル

Aptamer Group（UK）
Aptadel Therapeutics（USA）
SomaLogic Operating Co., Inc.（USA）
Base Pair Biotechnologies（USA）
Vivonics, Inc.（USA）
Aptagen, LLC（USA）
Aptus Biotech（Spain）
TriLink BioTechnologies（USA）
AM Biotechnologies, LLC（USA）
Maravai LifeSciences（USA）

結論と提言

Product Code: SQMIG35E2038

Aptamers Market size was valued at USD 2.91 billion in 2023 and is poised to grow from USD 3.63 billion in 2024 to USD 21.06 billion by 2032, growing at a CAGR of 24.6% during the forecast period (2025-2032).

The global market for aptamers is poised for significant growth, driven by the rising prevalence of chronic diseases and the increasing adoption of targeted therapeutics. The demand for early diagnostic solutions, backed by heightened investments in innovative diagnostic technologies, will further propel this market forward. Additionally, advancements in SELEX technology are expected to enhance aptamer development opportunities. The surge in medical research and development, coupled with a growing focus on genetic therapies and heightened awareness of aptamer benefits, positions the market for robust expansion. However, challenges such as short half-life, availability of alternatives, limited acceptance, and stringent regulatory frameworks may hinder growth. Notably, developed regions like the United States and Canada are emerging as promising markets for aptamer providers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Aptamers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Aptamers Market Segments Analysis

Global Aptamers Market is segmented by Type, Application, Technology, End-User and region. Based on Type, the market is segmented into DNA Aptamers, RNA Aptamers, XNA Aptamers, Peptide Aptamers and Aptamer-drug conjugates (ApDCs). Based on Application, the market is segmented into Diagnostics, Therapeutics, Research & Development, Biosensors and Drug Delivery Systems. Based on Technology, the market is segmented into SELEX and Post-SELEX Optimization Techniques. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Clinical Laboratories,Contract Research Organizations(CROs) and Diagnostic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Aptamers Market

The aptamers market is being propelled by the increasing investments in the advancement of drug delivery technologies, which have facilitated the emergence of targeted therapeutics. These therapeutics are gaining widespread acceptance globally due to their ability to minimize unexpected side effects, offering a safer alternative to traditional treatments. As a result, the utilization of aptamers in the development of these specialized drugs is contributing significantly to the growth of the market. With the rising demand for targeted therapies, the role of aptamers as key components in innovative drug development is becoming more prominent, driving further evolution in this sector.

Restraints in the Aptamers Market

The Aptamers market faces a significant constraint due to the notably brief half-life of aptamers, which typically spans just minutes to hours. This limited duration poses substantial challenges in identifying viable practical applications for these molecules. Efforts to manage the short half-life while preserving the unique characteristics of aptamers without degradation present a formidable obstacle. Consequently, these difficulties are anticipated to hinder the growth and demand for aptamers in the market in the coming years, as researchers and manufacturers struggle to optimize their stability and functionality for effective use in various applications.

Market Trends of the Aptamers Market

The global aptamer market is witnessing a significant trend towards the incorporation of chemical modifications to enhance aptamer stability and functionality. As researchers and aptamer providers increasingly focus on innovations such as PEGylation and locked nucleic acid (LNA) modifications, the market is expected to expand due to improvements in pharmacokinetics, target binding, and reduced degradation in biological systems. These advancements will not only broaden the application scope of aptamers in therapeutics and diagnostics but also cater to the growing demand for more efficient and durable biotherapeutics, positioning modified aptamers as a pivotal element in the biotechnology landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape

Global Aptamers Market Size by Type & CAGR (2025-2032)

Market Overview
DNA Aptamers
RNA Aptamers
XNA Aptamers
Peptide Aptamers
Aptamer-drug conjugates (ApDCs)

Global Aptamers Market Size by Application & CAGR (2025-2032)

Market Overview
Diagnostics
- Biomarker Detection
- Pathogen Detection
- Imaging Agents
- Companion Diagnostics
Therapeutics
- Oncology
- Cardiovascular Diseases
- Infectious Diseases
- Ophthalmology
- Inflammatory & Autoimmune Diseases
Research & Development
- Molecular Probes
- Target Validation
- Protein Interaction Studies
Biosensors
- Environmental Monitoring
- Food Safety
- Biodefense Applications
Drug Delivery Systems
- Targeted Delivery
- Controlled Release Formulations

Global Aptamers Market Size by Technology & CAGR (2025-2032)

Market Overview
SELEX
- Conventional SELEX
- Cell-SELEX
- Capillary Electrophoresis SELEX
- Microfluidic SELEX
- High-throughput SELEX
Post-SELEX Optimization Techniques
- Chemical Modifications
- Truncation
- Dimerization
- PEGylation

Global Aptamers Market Size by End-User & CAGR (2025-2032)

Market Overview
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Clinical Laboratories
Contract Research Organizations (CROs)
Diagnostic Laboratories

Global Aptamers Market Size & CAGR (2025-2032)

North America (Type, Application, Technology, End-User)
- US
- Canada
Europe (Type, Application, Technology, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Application, Technology, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Application, Technology, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Application, Technology, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Aptamer Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aptadel Therapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SomaLogic Operating Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Base Pair Biotechnologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vivonics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aptagen, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aptus Biotech (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TriLink BioTechnologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AM Biotechnologies, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Maravai LifeSciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

アプタマー市場規模、シェア、成長分析、タイプ別、用途別、技術別、エンドユーザー別、地域別 - 産業予測、2025-2032年

Aptamers Market Size, Share, and Growth Analysis, By Type (DNA Aptamers, RNA Aptamers), By Application (Diagnostics, Therapeutics), By Technology, By End-User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

アプタマー市場規模：タイプ別

アプタマー市場規模：用途別